For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

Semax Sourcing Review

Semax proposals need exact peptide identification and a route-specific evidence review. A nootropic label is not a quality standard or treatment authorization.

Reference variants

Add Semax to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 80714-61-0
    $12.65/vial$10.12/vial at 1,000+ vials of this item
    vials, packs of 10
  • 25mgSpray bottleCAS 80714-61-0
    $30.00/bottle$20.00/bottle at 50+ bottles of this item
    bottles

Review your order request · Compare the full catalog

Distinguish the named peptide from modified analogs

Require the full identity specification. A modified or acetylated analog should not be treated as identical to the material described in a study merely because the names resemble each other.

Avoid translating research directly into a protocol

Document what was studied, in whom, and by which route. Findings from a different preparation do not establish an appropriate clinic protocol or a permitted supply route.

Before a sourcing inquiry

For Semax, provide the exact substance or finished-product identity, intended transaction, facility type and destination state. Do not send patient information. A qualified reviewer must confirm the applicable pathway before purchasing.

  • Obtain product- and lot-specific identity and quality records before accepting material.
  • Verify storage, shipping and dating against the actual preparation, not a generic catalog range.
  • Request written confirmation of availability and terms; this page does not confirm stock, strength, price or supply eligibility.

We do not currently have verified COAs available to publish. No purity, sterility or lot-release result is established by this page.

Purchasing questions

Can a Semax analog use the same supporting evidence?

Not without a specific assessment. Structural changes may affect properties, and evidence for one substance does not establish another's safety or eligibility.

Match the named sequence and route

FDA identifies limited safety information and peptide-related impurity concerns for Semax. A modified analogue or another delivery route should not be treated as the same studied preparation.

Documentation to request

Ask for full identity, modification status and formulation details. Compare vial and spray documentation separately rather than transferring claims between them.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Non-clinical protocol review checklist. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. A compounded preparation is not FDA-approved. This reference is not medical or legal advice and does not establish a lawful supply route.

Ask about the review requirements

Ask what information is needed to assess a Semax inquiry. An inquiry is not confirmation that the product can be supplied.

Discuss sourcing requirements
Call Apply for Wholesale